GSE161422
Divergent resistance mechanisms to HER2-targeted therapies in breast cancer (scRNA-Seq)
Divergent resistance mechanisms to HER2-targeted therapies in breast cancer Overall design: scRNA-Seq of two HER2+ PDX models treated with chemotherapy or HER2-targeting agents